Displaying drugs 76 - 88 of 88 in total
Sirna-027
Sirna-027 is a chemically modified short interfering RNA(siRNA) targeting Vascular Endothelial Growth Factor Receptor-1(VEGFR-1). VEGFR-1 is a key component of the clinically validated vascular endothelial growth factor (VEGF) pathway. Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails. It is used to treat Macular...
Investigational
CTCE-0214
CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood cells.
Investigational
Hydromethylthionine mesylate
Investigational
PD-0299685
PD-0299685 is under investigation in clinical trial NCT00314964 (Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause).
Investigational
Zamerovimab
Investigational
VPO-227
Investigational
Mazorelvimab
Investigational
Witch hazel
Nutraceutical
Matched Products: … Mefactory 3step Piggy Nose Pack Step 02 Blackhead Clear Sheet ... Mefactory 3Step Piggy Nose Pore Strip Step 02 Blackhead Clearing Sheet …
Bis(2,2-dimethylpropanoyloxymethyl) VK-0214
Investigational
Anbenitamab
Investigational
Displaying drugs 76 - 88 of 88 in total